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Abstract
Background: Erysipelothrix rhusiopathiae is a zoonotic pathogen that causes erysipeloid and is most frequently
associated with exposure to domestic swine. Infection of native and prosthetic joints is a rarely reported manifestation.
Case presentation: We describe a case of E. rhusiopathiae prosthetic joint infection in a woman with a history of
exposure to wild animals in the Canadian Arctic. Patient management involved a 1-stage surgical revision exchange
with an antibiotic impregnated cement spacer and 6 weeks of intravenous penicillin G followed by 6 weeks of oral
amoxicillin. Ten previously reported cases of E. rhusiopathiae joint infection are reviewed. Recent increases in mortality
due to infection with this organism among host animal populations in the Canadian Arctic have generated concern
regarding a potential increase in human infections. However, whole genome sequencing (WGS) of the organism was
unable to identify a zoonotic origin for this case.
Conclusions: Consideration should be given to E. rhusiopathiae as a cause of joint infections if the appropriate
epidemiologic and host risk factors exist. Expanded use of WGS in other potential animal hosts and environmental
sources may provide important epidemiologic information in determining the source of human infections.
Keywords: Erysipelothrix rhusiopathiae, Prosthetic joint infection, Septic arthritis, Whole genome sequencing
Background
Erysipelothrix rhusiopathiae is the causative organism of
erysipeloid, a localized cutaneous infection [1–3]. Less
commonly, it is known to cause systemic infection with
or without endocarditis [1, 2, 4]. Infection is usually
associated with occupational exposure to infected host
animals and is most frequently reported following contact
with domestic swine [1–3, 5]. We report a case of E.
rhusiopathiae prosthetic joint infection (PJI) in a woman
with exposure to multiple wild host species in the Can-
adian Arctic. E. rhusiopathiae has recently been linked
to multiple muskox die-offs [6, 7] as well as the emer-
gence of a new disease syndrome in Arctic fox [8] in
these Arctic areas. This has generated concerns that an
increase in human infections might be observed, espe-
cially in regions where exposure to potentially infected
animals is expected to be greater [6].
Case presentation
A 69-year-old woman was seen in follow-up at an
outpatient orthopaedic clinic approximately 10 weeks
after completing a 3-month course of antibiotic therapy
for a right knee PJI due to Brucella suis, as reported pre-
viously [9]. She completely recovered following treatment
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of her B. suis PJI, but noted onset of acutely worsening
right knee pain, warmth, and overlying redness 1 day prior
to her scheduled follow-up. She was afebrile and systemic-
ally well.
An original total arthroplasty of the right knee was per-
formed 12 years prior and she was diagnosed with a B. suis
PJI after multiple synovial fluid aspirates grew the organ-
ism in 2015. She underwent irrigation and debridement
with removal of all prosthetic components and implant-
ation of a gentamicin, vancomycin, and ceftazidime im-
pregnated static cement spacer. She completed 10 days of
intravenous aminoglycoside therapy (initially tobramycin
and then gentamicin) combined with oral doxycycline and
rifampin. Oral antibiotics were continued for a total of 12
weeks. On initial follow-up, she had improved knee pain,
no fever, normalization of inflammatory markers and a
healed surgical wound.
The patient’s past medical history was otherwise sig-
nificant for obesity, hypertension, gastroesophageal re-
flux disease and osteoarthritis with chronic back pain.
Her medications were hydrochlorothiazide, ramipril, and
pantoprazole. She had no known allergies. The patient
lives on a remote island in the Canadian Arctic and works
as an artist. She would regularly butcher wild meat (in-
cluding caribou, muskox, seal and fish) and often con-
sumed the meat and fish raw.
On physical examination, she was non-toxic and
afebrile. Her right knee was swollen and erythematous.
She had a static cement spacer at the time of this assess-
ment and was not able to perform range of motion.
There was no apparent drainage or visible sinus tracts
on the right knee. The remainder of her physical exam-
ination was unremarkable.
Radiographs of the right knee revealed that the
position of the intramedullary pins and large spacer
was unchanged with no skeletal changes, however
diffuse soft tissue swelling was evident. Erythrocyte
sedimentation rate (ESR) and C-reactive protein
(CRP) had risen from normal levels 3 months earlier
to 49 mm/h and 171.4 mg/L respectively. Complete
blood count did not show leukocytosis or neutrophilia.
Serum creatinine was 66 μmol/L. A repeat Brucella IgG
plus IgM standard agglutination assay performed in the
previous month was negative with a titre of < 1:40. Given
the clinical suspicion for recurrent PJI, a right knee
arthrocentesis was performed in the orthopaedic out-
patient clinic, which revealed a synovial fluid white blood
cell count of 25,330 × 106/L comprised of 87% poly-
morphonuclear cells. No organisms were seen on direct
gram stain of the fluid.
A gram-positive bacillus was reported to be growing
from liquid media culture 2 days after collection. The
patient was taken back to the operating room the following
day where she had irrigation and debridement of the right
knee with removal of the previous prosthetic components
and reinsertion of a static cement spacer with 3.6 g of
tobramycin per bag of polymethylmethacrylate bone ce-
ment. Three bags of cement were used. No preoperative
antibiotics were given. Once intra-operative tissue speci-
mens had been collected, 2 g of cefazolin IV were given.
The organism recovered from the pre-operative knee
aspirate was confirmed as E. rhusiopathiae by 16S rRNA
sequencing at the Provincial Laboratory for Public Health
in Edmonton, Canada. This organism was also seen on
direct gram stain and eventually isolated from all 5 intra-
operative tissue specimens. Whole genome sequencing
was performed on two of these isolates using the Illumina
MiSeq platform. The 250 bp paired-end reads were as-
sembled de novo using SPAdes (v3.10.1), and the as-
semblies compared to sequence data from previously
isolated E. rhusiopathiae from various mammal car-
casses from the Canadian Arctic, isolates from domes-
tic swine and poultry as well as wild birds, mammals,
and fish originating from various locations in North
America and Europe [8]. This was done by generating
a core genome alignment and phylogenetic tree using
parsnp (Harvest Tools v1.2) (Fig. 1).
The isolate tested susceptible in vitro by E-test methods
to ampicillin (minimum inhibitory concentration (MIC)
0.094 μg/mL), ciprofloxacin (MIC 0.047 μg/mL), and
erythromycin (MIC 0.032 μg/mL) (interpreted according
to the current M45 Clinical and Laboratory Standards In-
stitute clinical breakpoints) and was reported resistant to
vancomycin as this is an intrinsic characteristic. Four
blood cultures, which were collected on the same day of
this visit to the orthopedic outpatient clinic and prior to
the administration of antibiotics, remained negative after
5 days of incubation. An echocardiogram was not per-
formed as it was felt that the patient was unlikely to have
endocarditis. She was initially treated with intravenous
ceftriaxone 1 g daily but was switched to intravenous peni-
cillin G once susceptibility results were available. She
completed 6 weeks of intravenous antibiotic therapy and
subsequently completed an additional 6 weeks of oral
amoxicillin 1 g three times daily.
On the last day of her oral antibiotic therapy she was
reviewed as an outpatient and was clinically well with no
fever and resolution of knee pain. Her surgical wound
had healed well with no evidence of recurrent infection
on physical examination. Her CRP and ESR had normal-
ized to 1.4 mg/L and 13mm/h respectively. She was
again seen in follow-up 4months later (approximately 8
months after her last surgery) and remained well with
no clinical evidence of relapse and CRP and ESR
remaining within normal limits at 0.9 mg/L and 15mm/
h respectively. The patient declined a second stage revi-
sion procedure and remained clinically well 1 year after
her last surgery.
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Discussion
E. rhusiopathiae is a ubiquitous, non-spore forming, fac-
ultative intracellular, gram-positive bacillus with a global
distribution [2]. While E. rhusiopathiae is a commensal
organism and a pathogen of a variety of domestic and
wild animals, it is also known to exist as an environmen-
tal saprophyte [1]. Human infection with this organism
is considered a zoonosis [1, 2]. The clinical spectrum of
E. rhusiopathiae infection in humans consists of three
major forms of disease: localized cutaneous infection,
diffuse cutaneous infection, and systemic infection. Lo-
calized cutaneous infection, also known as erysipeloid, is
the most common presentation and is usually described
as a subacute cellulitis at the site of inoculation, which
often resolves spontaneously within 3 weeks [1, 3]. Dif-
fuse cutaneous disease and systemic disease that involves
bacteremia with or without endocarditis is uncommon
[4]. Other uncommon manifestations reported include
pneumonia, abscesses, meningitis, endophthalmitis, osteo-
myelitis, and septic arthritis [1, 2].
Joint infection is a common occurrence in animals in-
fected with E. rhusiopathiae [5]. However, septic arthritis
of both native and prosthetic joints is a rarely reported
manifestation of the disease in humans. Only 6 native
joint infections and 4 PJIs with this organism have been
reported previously, which are summarized in Table 1.
The majority of clinical presentations were of a large
joint chronic monoarthritis that developed over several
months. Two cases had an acute presentation within
days of presumed exposure, one after a penetrating in-
jury to the shoulder [10] and the other occurring early
after arthroscopic knee surgery [11]. Systemic symptoms
and signs were absent in most cases, with only 2 patients
reporting fever. CRP was measured in most and was
moderately elevated.
A previously surmised finding is that many of the re-
ported cases had immunosuppressive conditions includ-
ing chronic lymphocytic leukemia, systemic lupus
erythematosus, diabetes mellitus, chronic renal failure,
hemodialysis, and corticosteroid use that likely predis-
posed them to invasive E. rhusiopathiae infection [12].
In this case, no immunosuppressive conditions were
known to exist. However, previous and recent surgery as
well as the presence of prosthetic material also likely in-
crease patient propensity to develop intra-articular infec-
tion with this organism, if conditions for exposure exist.
A definitive diagnosis of E. rhusiopathiae infection
largely still relies on culture techniques, which have vari-
able sensitivity depending on the organism burden
present in the specimen collected [1]. While organisms
Fig. 1 Whole genome sequencing comparison of the Erysipelothrix rhusiopathiae isolates from the present human prosthetic joint infection case
(shown by red star) with other Clade 3 isolates from swine, poultry and various wildlife species. The tree is rooted to the reference Fujisawa strain
(intermediate clade). The blue star highlights the strain found in multiple hosts from Banks, Victoria, and Prince Patrick Islands in Nunavut
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were only seen on direct gram stain of surgical tissues
from the current joint infection case and specimens of
one of the previously reported cases, E. rhusiopathiae
was eventually recovered from all cases by culture
methods. Identification using basic and automated bio-
chemical systems as well as mass spectrometry technol-
ogy, such as matrix assisted laser desorption/ionization
time of flight, reliably identifies this organism [13]. Mo-
lecular diagnostic techniques, including sequencing of
the conserved regions of the gene encoding 16S rRNA,
are also a specific way to confirm identification [14]. Use
of species-specific molecular diagnostic tests (i.e. poly-
merase chain reaction) directly on clinical specimens
such as joint fluid may also be a sensitive and specific
way to detect the presence of E. rhusiopathiae genetic
material, particularly if there is high clinical suspicion
and culture methods fail to recover the organism.
E. rhusiopathiae is intrinsically resistant to aminogly-
cosides and vancomycin but susceptible to penicillins,
broad spectrum cephalosporins and fluoroquinolones,
with no documented resistance to these agents [1, 2, 15].
The treatment of choice for localized and systemic infec-
tions is penicillin or ampicillin [1–4]. The ideal anti-
biotic regimen and duration for joint infections with this
organism is unknown. It is recommended that native
joint infections caused by other more common organ-
isms be managed with a combination of drainage or sur-
gery and antibiotic therapy [16, 17], and that PJIs be
managed with surgery and antibiotics [18]. Management
of previously reported E. rhusiopathiae joint infection
cases has largely involved a combination of surgical
intervention and antibiotic therapy (Table 1). Antibiotic
decisions should be based on in vitro susceptibility re-
sults and individualized for each patient.
Transmission of E. rhusiopathiae to humans occurs
after exposure to animals carrying or infected with the or-
ganism, or to their products [1–4]. Transmission following
exposure to environmental sources harbouring the organ-
ism has also been reported [1]. The organism usually en-
ters through non-intact skin, although infection following
ingestion has been reported as well [1, 3]. In 4 of the 10
previously reported joint infection cases, E. rhusiopathiae
was thought to gain access to the affected joint by con-
tiguous spread from an overlying skin infection. One joint
was presumed to be have been seeded hematogenously
from an infected aortic valve [19]. The pathogenesis of the
remaining 4 cases was unknown. The pathogenesis of the
present case is unclear, however she did have a healing op-
erative wound from the recent surgery when she reported
handling wild muskox and other animal meat. E. rhusio-
pathiae may have been inoculated into this wound while
she was handling meat from these potential source ani-
mals and, like previous cases, spread contiguously into her
knee joint.
Most infections with E. rhusiopathiae are described in
the setting of an occupational exposure to domestic ani-
mals with veterinarians, butchers, farmers, and fisher-
men being among those at highest risk [1, 2, 20]. Swine
are described as the major reservoir for human infection
that occurs in occupational settings, however multiple
other animals are known to carry the organism, includ-
ing Arctic marine mammals, fish, foxes and muskoxen
[1, 2, 5, 6, 8]. Therefore, hunting and food practices of
local populations in the Canadian Arctic are also known
to increase risk for infection with E. rhusiopathiae [1, 6].
Multiple large-scale die-offs of muskoxen due to E. rhu-
siopathiae that have been reported in the Canadian Arc-
tic in recent years, many on the same remote island as
the case reported here [6], signal a changing epidemi-
ology of this infection in mammals that may have an im-
pact on human health in the region.
A comparison of whole genome sequences (WGS) gen-
erated from E. rhusiopathiae isolates found in these
muskox carcasses between 2010 and 2013 previously re-
vealed that a single strain was associated with die-off
events across two large islands [21]. As part of an ongoing
surveillance program in the Canadian arctic, further iso-
lates collected in 2017 from muskoxen and seals on the
same islands, and from muskoxen on a neighbouring but
distant island identified that this same strain is still
broadly circulating (Mavrot et al., unpublished). However,
based on WGS comparisons, the isolate from this human
case of PJI is not genetically related to the E. rhusiopathiae
strain found in these arctic animal species and is more
closely related to isolates found in poultry species as well
as swine isolates from Canada and Belgium (Fig. 1), al-
though the patient had no reported exposure to poultry or
swine. This suggests that the patient acquired her infec-
tion from another animal or environmental source which
WGS was not able to elucidate in this case given lacking
epidemiologic linkages. Further investigations into the epi-
demiology of this pathogen in the Canadian Arctic, includ-
ing the use of WGS and expanding testing to migratory
birds and fish, could help to assess the likelihood of other
animal and/or environmental sources as the cause of hu-
man zoonotic infections [21].
The prevalence of zoonotic infections in humans, like
those caused by E. rhusiopathiae, is influenced by a
number of factors including the burden of disease within
the animal reservoir(s) [22, 23]. Animals may become
more susceptible to a particular organism as changes to
host-environment-pathogen interactions occur [6, 23].
One such driving factor cited for the changing epidemi-
ology of many zoonotic infections is climate change
[22–24]. It has been postulated that the prevalence of E.
rhusiopathiae in certain animal host populations in the
Canadian Arctic, such as muskoxen, is increasing partly
as a result of climate change [6]. Kutz et al. who have
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been examining the epidemiology of E. rhusiopathiae in
the Canadian Arctic expressed concern about the poten-
tial for zoonotic infection and emphasized the need for
public health education and messaging to ensure that
these important food sources continue to be harvested
and handled in a way that prevents human exposure [6].
Guidelines for hunters in the Canadian North recom-
mend that animals found dead not be touched or eaten,
advise against cutting into animal parts that look abnor-
mal, and whenever in doubt, to cook the meat or fish
well [25, 26].
Infections with E. rhusiopathiae are not reportable to
local or national health authorities in Canada. Without
an epidemiological database for tracking infections, it is
unknown if incidence of this infection in humans is in-
creasing. Nonetheless, changes to the burden of disease
in host animal populations are likely to result in an in-
creased risk to those who rely on and are exposed to
these animals and their environment on a regular basis.
Our case experienced consecutive zoonotic infections of
a prosthetic joint with B. suis followed by E. rhusio-
pathiae. Given the spread of E. rhusiopathiae among
local wildlife in the Canadian Arctic, and the increased
potential for human infection, consideration should be
given to public health surveillance of this infection in
this geographic region.
Conclusion
E. rhusiopathiae joint infection is a rarely reported clin-
ical entity, usually occurring in humans when host de-
fences are debilitated. The present case occurred after
exposure to the products of various potential host ani-
mals in the Canadian Arctic including muskoxen, which
have suffered large-scale die-offs in recent years due to
infection with this organism. Changing environmental
conditions may be contributing to the increased burden of
carriage or disease in certain host populations, thereby in-
creasing the risk of infection to those who regularly interact
with these animals or their environments. Since this infec-
tion is not a notifiable disease in Canada, consideration
should be given to making it an infection under public
health surveillance to allow the tracking of future human
cases. Finally, expanding testing and subsequent WGS to
other potential vertebrates and other environmental
sources is likely to provide important epidemiologic infor-
mation in determining the source of human infections.
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